🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,76 USD

Máx. histórico

156,45

76 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,92%

Rango 52 semanas

85,80 – 156,92

Variación hoy

+1,38%

Cierre anterior

146,73

Rango de hoy

146,52 – 148,80

Volumen hoy

7.557.172

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
150,26 (puede no estar actualizado)
Dividend yield
2,32% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 18 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
11/06/2015 0,4294 USD
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/01/2023 109,34 111,31 108,75 111,07 +0,23% 2,34% 8.626.500
10/01/2023 110,56 112,01 109,88 110,81 +0,39% 1,93% 12.122.800
09/01/2023 114,88 114,93 109,94 110,38 -3,88% 4,34% 12.858.800
06/01/2023 114,32 115,49 114,05 114,84 +1,06% 1,26% 8.632.300
05/01/2023 111,59 113,91 111,42 113,64 +1,39% 2,23% 9.578.900
04/01/2023 112,32 112,61 111,24 112,08 +0,85% 1,22% 8.698.600
03/01/2023 110,41 111,20 109,49 111,14 +0,17% 1,55% 8.062.500
30/12/2022 111,23 111,42 110,12 110,95 +0,12% 1,17% 5.498.600
29/12/2022 111,39 111,70 110,75 110,82 -0,23% 0,85% 4.467.200
28/12/2022 112,89 112,89 111,06 111,08 -0,93% 1,62% 5.107.800
27/12/2022 112,41 112,59 111,53 112,12 +0,23% 0,94% 5.125.800
23/12/2022 111,25 112,13 110,87 111,86 +0,56% 1,13% 4.547.400
22/12/2022 110,90 111,69 110,21 111,24 +0,12% 1,33% 8.373.700
21/12/2022 110,10 111,19 109,54 111,11 +1,28% 1,50% 6.640.900
20/12/2022 109,94 110,66 109,16 109,71 +0,25% 1,36% 8.022.000
19/12/2022 109,19 110,10 108,77 109,44 +0,22% 1,22% 6.949.500
16/12/2022 109,24 109,70 108,27 109,20 -0,39% 1,31% 29.465.900
15/12/2022 110,24 110,77 109,23 109,63 -1,72% 1,40% 9.871.400
14/12/2022 110,52 112,17 110,04 111,55 +0,58% 1,93% 10.788.300
13/12/2022 111,26 111,26 109,00 110,91 +1,78% 2,03% 15.836.900
12/12/2022 107,93 109,10 107,32 108,97 +0,17% 1,65% 10.956.600
09/12/2022 110,98 111,37 108,75 108,78 -1,87% 2,36% 9.667.800
08/12/2022 110,28 111,02 110,12 110,85 +0,69% 0,82% 7.354.800
07/12/2022 109,15 110,71 109,00 110,09 +1,06% 1,57% 8.270.400
06/12/2022 110,36 110,76 108,42 108,93 -0,98% 2,12% 7.458.700
05/12/2022 109,81 110,23 109,21 110,01 -0,03% 0,93% 6.961.900
02/12/2022 109,00 110,09 108,71 110,04 +0,22% 1,27% 6.943.600
01/12/2022 109,75 110,98 108,77 109,80 -0,29% 2,01% 10.110.500
30/11/2022 108,70 110,33 107,63 110,12 +1,18% 2,48% 20.305.800
29/11/2022 108,00 109,06 107,55 108,84 +0,36% 1,40% 9.352.400